IMPROVEMENTS RELATING TO CANCER THERAPIES

摘要

Hypomethylation of the L1 retrotransposon sequence is demonstrated in cancerous cells. The invention provides the use of a retrotransposon, in particular the L1 sequence, as a promoter to control gene expression in a method of gene therapy.